Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 1
2001 3
2002 3
2003 4
2004 1
2005 3
2006 2
2007 2
2008 2
2009 2
2010 3
2011 2
2012 5
2013 4
2014 5
2015 7
2016 5
2017 2
2018 3
2019 3
2020 5
2021 7
2022 8
2023 8
2024 12
2025 17
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

109 results

Results by year

Filters applied: . Clear all
Page 1
Experience with stem cell therapy in neonates: Hope or disappointment?
Bilgin L, Celik T, Ince Z, Yigit S, Coskun Y, Gursoy T, Yildirim S, Terek D, Akisu M, Akduman H, Dilli D, Okulu E, Atasay B, Yilmaz A, Aladag N, Acunas B, Colak R, Ozdemir SA, Celik K. Bilgin L, et al. Among authors: colak r. Early Hum Dev. 2025 Aug;207:106310. doi: 10.1016/j.earlhumdev.2025.106310. Epub 2025 Jun 2. Early Hum Dev. 2025. PMID: 40480019
First-Line Chemotherapy Versus CDK4/6 Inhibitors in HR-Positive, HER2-Negative Breast Cancer with Liver Metastases: A Multicenter Real-World Data.
Fidan MC, Öztürk AE, Aydın O, Akdağ G, Türkoğlu E, Çolak R, Majidova N, Kapağan T, Guliyev M, Çelik E, Odabaş H, Yılmaz M, Bayoğlu İV, Bulut N, Demirci NS, Alan Ö. Fidan MC, et al. Among authors: colak r. J Clin Med. 2025 Jun 27;14(13):4568. doi: 10.3390/jcm14134568. J Clin Med. 2025. PMID: 40648939 Free PMC article.
Real-life data on adjuvant trastuzumab emtansine treatment in early-stage HER2-positive breast cancer: a Turkish Oncology Group study.
Akturk Esen S, Seven I, Akdere Ates G, Colak R, Kinikoglu O, Akay Hacan B, Bakkal Temi Y, Sever N, Kahraman S, Arak H, Topcu A, Saray S, Akbas S, Beypinar İ, Acar O, Erdoğan AP, Yilmaz M, Isik D, Ates O, Cabuk D, Sendur MAN, Uncu D. Akturk Esen S, et al. Among authors: colak r. Anticancer Drugs. 2025 Aug 1;36(7):575-582. doi: 10.1097/CAD.0000000000001717. Epub 2025 Apr 1. Anticancer Drugs. 2025. PMID: 40162996
Induction or Adjuvant Chemotherapy in Patients with Locally Advanced Nasopharyngeal Cancer Receiving Chemoradiotherapy? A Turkish Oncology Group Study.
Sekmek S, Oguz A, Karakurt Eryilmaz M, Araz M, Biter S, Kıdı MM, Bayram E, Erdat EC, Yasar A, Colak R, Yilmaz M, Bakir Kahveci G, Divriklioglu D, Chalabiyev E, Aksoy S, Ozsan Celebi SN, Kosku H, Yılmaz M, Hacibekiroglu I, Temizyurek H, Canaslan K, Turhan G, Kadıoglu A, Jeral S, Atak M, Atacan H, Ozbay A, Atasever T, Seyyar M, Can Sanci P, Koylu B, Majidova N, Arpaci E, Akinci MB, Uncu D, Ucar G. Sekmek S, et al. Among authors: colak r. J Clin Med. 2025 Jun 12;14(12):4189. doi: 10.3390/jcm14124189. J Clin Med. 2025. PMID: 40565933 Free PMC article.
The impact of carboplatin on pathologic complete response and survival based on HER2 low and HER2 zero status in triple negative breast cancer patients receiving neoadjuvant chemotherapy: a multicenter real-world analysis.
Yıldırım S, Başoğlu T, Doğan A, Akdağ G, Kınıkoğlu O, Topal A, Alan O, Solmaz AA, Gürbüz M, Çil T, Çolak R, Yılmaz M, Kalem A, Sever N, Majıdova N, Karakoyun K, Sekmek S, Saçlı O, Ozcelık M, Işık D, Surmeli H, Sever ON, Odabas H, Yıldırım ME, Turan N. Yıldırım S, et al. Among authors: colak r. BMC Cancer. 2025 May 6;25(1):833. doi: 10.1186/s12885-025-14252-3. BMC Cancer. 2025. PMID: 40329228 Free PMC article.
109 results